Suppression of PP2A-B56Ξ± drives EMT in EGFR mutant non-small cell lung cancer
Oncogene, Published online: 11 April 2026; doi:10.1038/s41388-026-03772-2
Suppression of PP2A-B56Ξ± drives EMT in EGFR mutant non-small cell lung cancerOncogene, Published online: 11 April 2026; doi:10.1038/s41388-026-03772-2
Suppression of PP2A-B56Ξ± drives EMT in EGFR mutant non-small cell lung cancerOncogene, Published online: 11 April 2026; doi:10.1038/s41388-026-03725-9
HERC1 oncogene enhances stemness and tumorigenic potential in CD44+-derived organoids of head and neck squamous cell carcinoma through IL-6/STAT3 signalingOncogene, Published online: 10 April 2026; doi:10.1038/s41388-026-03731-x
Wnt signaling and the tumor microenvironment: implications for cancer progression and therapeuticsOncogene, Published online: 10 April 2026; doi:10.1038/s41388-026-03771-3
The impact of K-Ras Gly12 mutants on homeostasis and tumorigenesis in the colonic epitheliumOncogene, Published online: 09 April 2026; doi:10.1038/s41388-026-03775-z
Plasmin promotes hepatocellular carcinoma invasion and metastasis via CXCR4-mediated activation of PI3K/AKT/mTOR signalingOncogene, Published online: 08 April 2026; doi:10.1038/s41388-026-03758-0
Multi-omics approaches reveal erythroid progenitor cell in cancer: from passive bystander to active playerOncogene, Published online: 07 April 2026; doi:10.1038/s41388-026-03753-5
PIAS4 inhibition induces cell cycle arrest and exhibits a synergistic effect in combination with CDK4/6 inhibitor in breast cancer treatment